[Cutaneous cancers after organ transplantation]

Area of Science:

• Oncology
• Immunology
• Dermatology

Background:

• Organ transplantation necessitates immunosuppressive therapy, increasing risks of infection and neoplasia.
• Cutaneous carcinomas are the most common malignancies post-transplantation.
• The ratio of squamous to basal cell carcinoma is altered in transplant recipients.

Purpose of the Study:

• To review the risk factors, clinical presentation, and management of post-transplant cutaneous carcinomas.
• To highlight the role of immunosuppressive drugs and sun exposure in carcinogenesis.
• To emphasize preventive and therapeutic strategies for these malignancies.

Main Methods:

• Literature review focusing on post-transplant malignancies.
• Analysis of risk factors including immunosuppression, sun exposure, and phototype.
• Discussion of clinical characteristics and treatment modalities.

Main Results:

• Immunosuppressive drugs impair immunosurveillance and may have direct carcinogenic effects.
• Fair skin phototype and cumulative sun exposure are significant risk factors.
• Post-transplant carcinomas are often multiple, aggressive, and have a reversed histology ratio.

Conclusions:

• Strict sun protection and optimized immunosuppression are key preventive measures.
• Early and complete surgical excision with histological confirmation is the primary treatment.
• Management requires careful consideration of prognostic factors and potential for recurrence.